Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001596771-19-000041

Options or other derivatives

  • Chief Technology Officer acquired 129,445 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mertens Steve · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-05-13 Grant or award : show line 1 in the form Option to Purchase Common Stock +129,445 $2.38 2029-05-13 129,445 129,445 D
Loading xslF345X03/primary_doc.xml…